72 related articles for article (PubMed ID: 19143854)
1. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.
Visco AG; Brubaker L; Richter HE; Nygaard I; Paraiso MF; Menefee SA; Schaffer J; Lowder J; Khandwala S; Sirls L; Spino C; Nolen TL; Wallace D; Meikle SF;
N Engl J Med; 2012 Nov; 367(19):1803-13. PubMed ID: 23036134
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity.
Tannenbaum S; den Adel M; Krauwinkel W; Meijer J; Hollestein-Havelaar A; Verheggen F; Newgreen D
Pharmacol Res Perspect; 2020 Dec; 8(6):e00684. PubMed ID: 33231929
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder.
Hu Y; Zhang H
BMC Urol; 2024 Apr; 24(1):97. PubMed ID: 38664686
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of High-Dose Vitamin D Supplementation vs Solifenacin or Standard Urotherapy for Overactive Bladder Dry in Children: A Randomized Clinical Trial.
Chen H; Zhang Z; Wu S; Zhang D; Zhong X; Liu X; Wei G
J Urol; 2024 Jan; 211(1):26-36. PubMed ID: 37871329
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study.
Ewerton F; Cruz F; Kapp M; Klein S; Roehm P; Chapple C
Eur Urol Focus; 2024 Jan; 10(1):90-97. PubMed ID: 37563004
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial.
Batista JE; Kölbl H; Herschorn S; Rechberger T; Cambronero J; Halaska M; Coppell A; Kaper M; Huang M; Siddiqui E;
Ther Adv Urol; 2015 Aug; 7(4):167-79. PubMed ID: 26445596
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial evaluating low-intensity shockwave therapy for treatment of persistent storage symptoms following transurethral surgery for benign prostatic obstruction.
Hegazy M; Sheir KZ; Gaballah MA; Elshal AM
Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):305-311. PubMed ID: 38553627
[TBL] [Abstract][Full Text] [Related]
8. HYPERACTIVE BLADDER SYNDROME SECONDARY TO BAROTRAUMA AND CHRONIC STRESS.
Filip SS; Slyvka RM; Batchynsky AI
Wiad Lek; 2023; 76(11):2401-2405. PubMed ID: 38112356
[TBL] [Abstract][Full Text] [Related]
9. What if there is no prospective, double blind, randomised trial?
de Groot JR
Neth Heart J; 2019 Oct; 27(10):459-461. PubMed ID: 31372839
[No Abstract] [Full Text] [Related]
10. The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: a systematic review.
Evans CNB; Badenhorst A; Van Wijk FJ
BMC Womens Health; 2024 May; 24(1):290. PubMed ID: 38755593
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of efficacy and safety of approved oral therapies for overactive bladder: a systematic review and network meta-analysis.
He W; Huang G; Cui W; Tian Y; Sun Q; Zhao X; Zhao Y; Li D; Liu X
Int Braz J Urol; 2023; 49(5):535-563. PubMed ID: 37506033
[TBL] [Abstract][Full Text] [Related]
12. Clinical optimal dose of solifenacin succinate for nursing patients after transurethral resection of the prostate during the perioperative period.
Zhang B; Wei J; Wu X; Wang L; Huo H; Wang J
Exp Ther Med; 2018 Feb; 15(2):1660-1665. PubMed ID: 29434751
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Anticholinergic Agents for Lower Urinary Tract Symptoms.
Goodson AB; Cantrell MA; Shaw RF; Lund BC
J Manag Care Spec Pharm; 2018 Jan; 24(1):65-72. PubMed ID: 29290176
[TBL] [Abstract][Full Text] [Related]
14. Antimuscarinic Agent Treatment Affecting Patient-Reported Outcomes in Overactive Bladder Syndrome With Depressive Symptoms.
Kim KS; Moon HS
Int Neurourol J; 2016 Dec; 20(4):349-355. PubMed ID: 28043114
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial to compare the safety and efficacy of tamsulosin, solifenacin, and combination of both in treatment of double-j stent-related lower urinary symptoms.
Shalaby E; Ahmed AF; Maarouf A; Yahia I; Ali M; Ghobish A
Adv Urol; 2013; 2013():752382. PubMed ID: 24235970
[TBL] [Abstract][Full Text] [Related]
16. Solifenacin for overactive bladder: a systematic review and meta-analysis.
Luo D; Liu L; Han P; Wei Q; Shen H
Int Urogynecol J; 2012 Aug; 23(8):983-91. PubMed ID: 22310924
[TBL] [Abstract][Full Text] [Related]
17. Comparative Evaluation of the Safety and Efficacy of Long-Term Use of Imidafenacin and Solifenacin in Patients with Overactive Bladder: A Prospective, Open, Randomized, Parallel-Group Trial (the LIST Study).
Zaitsu M; Mikami K; Ishida N; Takeuchi T
Adv Urol; 2011; 2011():854697. PubMed ID: 22046182
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of solifenacin succinate in Korean patients with overactive bladder: a randomised, prospective, double-blind, multicentre study.
Choo MS; Lee JZ; Lee JB; Kim YH; Jung HC; Lee KS; Kim JC; Seo JT; Paick JS; Kim HJ; Na YG; Lee JG
Int J Clin Pract; 2008 Nov; 62(11):1675-83. PubMed ID: 19143854
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
